Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas

OBJECTIVE: We estimate the effect size of hypoglycemia risk reduction on closed-loop control (CLC) versus open-loop (OL) sensor-augmented insulin pump therapy in supervised outpatient setting. RESEARCH DESIGN AND METHODS: Twenty patients with type 1 diabetes initiated the study at the Universities o...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kovatchev, Boris P., Renard, Eric, Cobelli, Claudio, Zisser, Howard C., Keith-Hynes, Patrick, Anderson, Stacey M., Brown, Sue A., Chernavvsky, Daniel R., Breton, Marc D., Mize, Lloyd B., Farret, Anne, Place, Jérôme, Bruttomesso, Daniela, Del Favero, Simone, Boscari, Federico, Galasso, Silvia, Avogaro, Angelo, Magni, Lalo, Di Palma, Federico, Toffanin, Chiara, Messori, Mirko, Dassau, Eyal, Doyle, Francis J.
Формат: Artigo
Язык:Inglês
Опубликовано: American Diabetes Association 2014
Предметы:
Diabetes Care Symposium
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4067397/
https://ncbi.nlm.nih.gov/pubmed/24929429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-2076
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы